Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: MiniMed

This article was originally published in The Gray Sheet

Executive Summary

MiniMed: Expects to net $29.7 mil. from an initial public offering of 2.5 mil. shares to be sold for $13 each. The insulin pump manufacturer is working with Hoechst to prepare a PMA/NDA submission for its implantable insulin pump; the pump uses insulin manufactured by Hoechst. Submission is anticipated "in 1995 or early 1996," according to the filing. Currently, $32.5 mil. of MiniMed's total revenues ($36.3 mil. in 1994) are generated by its external pumps for diabetes. MiniMed's 506 pump is used only for insulin; the firm's 404-SP general purpose pump may be used with other medications as well as insulin.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004208

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel